| FDA Office of Minority Health and Health Equity June 4, 2021  The Office of Minority Health and Health Equity (OMHHE) continues to work to promote and protect the health of racial and ethnic minorities, underrepresented and underserved populations through research and communication strategies that address health disparities.
As part of OMHHE's continued efforts to advance health equity, I'm pleased to announce OMHHE's Enhance EQUITY Initiative, a scientific initiative to amplify EQUITY in clinical trials, EQUITABLE data efforts and EQUITY of voices.
OMHHE's Enhance EQUITY Initiative highlights research projects and communication resources to enhance EQUITY in clinical trials by supporting efforts to advance clinical trial diversity, EQUITABLE data efforts by increasing demographic data including, but not limited to, ethnicity, race, age, disability and geography, and EQUITY of voices by amplifying FDA's communication with diverse groups and to ensure stakeholders, including consumers, are informed about FDA's efforts.
We look forward to continuing to expand our efforts in advancing health equity through the Enhance EQUITY Initiative. Achieving health equity requires commitment and dedication from stakeholders from all corners of the public health and research community. Together we can continue to make a difference. You can learn more about the Enhance EQUITY Initiative by visiting OMHHE's website. Sincerely,
RADM Richardae Araojo, PharmD, MS
Associate Commissioner for Minority Health
Director, Office of Minority Health and Health Equity Visit the FDA OMHHE website and follow us on Twitter at @FDAHealthEquity
"Creating a world where health equity is a reality for all."
www.fda.gov/HealthEquity  | | | |
No comments:
Post a Comment